Development of Monoclonal Antibody Products Targeting SARS-CoV-2 for Emergency Use Authorization - FDA Guidance Document

Development of Monoclonal Antibody Products Targeting SARS-CoV-2 for Emergency Use Authorization - FDA Guidance Document | Global Key Solutions